Brief: China Regenerative Medicine International Posts FY Loss Attributable To Owners Of Co Of HK$158.5 Mln
28/03/2018 24:02
March 28 (Reuters) - China Regenerative Medicine
International Ltd 8158.HK :
* FY REVENUE HK$503.7, UP 41.1%
* FY LOSS ATTRIBUTABLE TO OWNERS OF CO HK$158.5 MILLION
VERSUS
LOSS OF HK$184.5 MILLION
Source text for Eikon: ID:nHKSc9jZ9z
Further company coverage: 8158.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital